SGLT2 inhibitor empagliflozin could be a new treatment for children with type 2 diabetes: lancet

Published Date: 04 Mar 2023

United States: Empagliflozin could be a new treatment option for children and adolescents with type 2 diabetes, with phase 3 clinical trials showing...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Which women need more than mammograms for breast cancer screening?

2.

Implant-based reconstruction linked to increased risk of breast lymphomas

3.

Prostate cancer screening seems to be improved by PSA, biomarker testing, and MRI combined.

4.

New CAR T-Cell Therapy Approved for Leukemia

5.

Alarm Over Pharma-China Link; Taking Screening to the People; Agriculture and Cancer


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot